Article

Antibodies elicited by the 2025-2026 influenza vaccine in humans

2026-01-06

Abstract excerpt

A new H3N2 variant (named subclade K) possesses several key hemagglutinin substitutions and is circulating widely during the 2025-2026 influenza season. In this report, we completed experiments to determine if the 2025-2026 seasonal influenza vaccine elicits antibodies in humans that recognize this variant. We find that H3N2 subclade K viruses are antigenically advanced; however, the 2025-2026 seasonal influenza v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d94dea2-dad5-5bd2-b545-debde894983b
DOI: 10.64898/2026.01.05.26343449

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antibodies elicited by the 2025-2026 influenza vaccine in humansDOI 10.64898/2026.01.05.26343449Read

Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccineSemantic proximity Read

Mutational antigenic landscape of prevailing H9N2 influenza virus hemagglutinin spectrum.Semantic proximity Read

Loss of hemagglutination ability by H3N2 influenza A virus, subclade KSemantic proximity Read

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selectionSemantic proximity Read

Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adultsSemantic proximity Read

Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza seasonSemantic proximity Read

Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza seasonSemantic proximity Read

Immunoinformatics-Guided Design and In Silico Evaluation of a Multi-Epitope Vaccine Against Influenza A H10N5 and H3N2 Strains Based on Hemagglutinin and Neuraminidase ProteinsSemantic proximity Read

Antigenic and virological properties of an H3N2 variant that continues to dominate the 2021–22 Northern Hemisphere influenza seasonSemantic proximity Read

Targeting H3N2 Influenza: Advancements in Treatment and Vaccine StrategiesSemantic proximity Read

Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023Semantic proximity Read

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in CanadaSemantic proximity Read